Vertudazo, Anita .

HRN: 51-89-99  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/18/2022
CEFTAZIDIME 1GM (VIAL)
09/18/2022
09/23/2022
IV
2g
Q8h
Ascending Cholangitis, Cholelithiasis
Waiting Final Action 
09/18/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/18/2022
09/25/2022
IV
500mg
Q8h
Ascending Cholangitis, Cholelithiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: